Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,173.91
(
0.12%
)
US TECH 100
26,593.20
(
0.14%
)
Dow Jones
49,310.32
(
0.00%
)
Brent Oil
102.11
(
0.57%
)
Bitcoin
76,877.63
(
-2.26%
)
News Focus
News Focus
Post# of 16771
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

tcm55

Send PM Follow Ignore
Followers 16
Posts 1065
Boards Moderated 0
Alias Born 09/01/2019

tcm55

Re: None

Wednesday, 09/22/2021 10:37:00 AM

Wednesday, September 22, 2021 10:37:00 AM

Post# of 16771
"In the pre-IND meeting request application, the Company is confirming the direction it plans to take in the development of Ifenprodil as an adjunct to Topotecan for the treatment of chemo refractory SCLC."

The worm turns, deserter returns...GLTA...
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AGNPF News
More AGNPF News